InvestorNewsBreaks — MetAlert Inc. (MLRT) Enters Agreement with HFH to Add AI Mobile Health Solution to Service Offerings

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, has inked an agreement with HandsFree Health (“HFH”) to expand its service offerings. According to the agreement, MLRT will now be able to offer HFH’s Go Digital Health Tool to its customers; the HFH solution is a mobile health solution designed to support compliance and healthcare management. The app also includes access to a nationwide urgent care telehealth service. MetAlert announced that it will begin early enrollment for the service on July 1, 2023. Those using the app will be able to track key health indicators, including blood pressure, glucose, heart rate, temperature and weight; chart their progress; schedule appointments and reminders; and search for providers. The app also features the WellBe(R) HIPAA-compliant smart health assistant. The voice-enabled digital health platform uses AI to help connect users, caregivers, families, and even businesses to key health and wellness information.

“This is one more piece of MetAlert’s 360-degree approach to provide additional subscription services for comprehensive remote patient monitoring and long-term predictive analytics, to the ADA community we serve,” said MetAlert CEO Patrick Bertagna in the press release. “With our patented GPS SmartSole plus 3D infrared RoomMate for indoor remote-patient monitoring, and now adding telehealth urgent care and WellBe (your AI smart health assistant), MetAlert is able to provide a host of data collection wearable devices, wander assistance with real-time recovery, fall-prevention assistance, remote urgent-care assistance, and symptoms and treatment assistance, all under one platform, with easy monthly payments.”

To view the full press release, visit https://ibn.fm/DHjkL

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With more than 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technologies, enabling caregivers to track and monitor patients in real time. The company is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.